Paper10693878
Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia.
Wolfe F and 2 others. Arthritis Rheum, 2000. Cited by 183 papers, by iCite.
Cite this record
ConductScience Library. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Papers, record 10693878. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10693878
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetaminophen | Major topic |
| Anti-Inflammatory Agents, Non-Steroidal | Major topic |
| Rheumatic Diseases | Major topic |
| Aged | |
| Arthritis, Rheumatoid | |
| Female | |
| Fibromyalgia | |
| Humans | |
| Logistic Models | |
| Male | |
| Middle Aged | |
| Osteoarthritis | |
| Patient Satisfaction |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AR-43584 | NIAMS NIH HHS | United States | P01AR043584 | PubMed and NIH |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03771755 | Ibuprofen IV vs Acetaminophen IV for the Treatment of Pain Following Orthopaedic Low Extremity Surgery | Background |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 11665992 | A critique of the 2000 update of the American College of Rheumatology recommendations for management of hip and knee osteoarthritis. | https://conductscience.org/library/papers/11665992 |
Source PubMed
Cited by63
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 183 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41183802 | Visualizing Real-World Pain Treatment Pathways in Chronic Disease: A Sequence-Based Analysis of Polypharmacy in Systemic Lupus Erythematosus. | ACR Open Rheumatol | 2025 | https://conductscience.org/library/papers/41183802 | PubMed |
| 36030796 | Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents. | Lancet Infect Dis | 2023 | https://conductscience.org/library/papers/36030796 | PubMed |
| 35900204 | Does anti-nerve growth factor monoclonal antibody treatment have the potential to replace nonsteroidal anti-inflammatory drugs and opioids in treating hip or knee osteoarthritis? A systematic review of randomized controlled trials. | EFORT Open Rev | 2022 | https://conductscience.org/library/papers/35900204 | PubMed |
| 34236617 | Fibromyalgia in Older Individuals. | Drugs Aging | 2021 | https://conductscience.org/library/papers/34236617 | PubMed |
| 33159281 | Efficacy and safety of tanezumab administered as a fixed dosing regimen in patients with knee or hip osteoarthritis: a meta-analysis of randomized controlled phase III trials. | Clin Rheumatol | 2021 | https://conductscience.org/library/papers/33159281 | PubMed |
| 29890922 | Controlled release of celecoxib inhibits inflammation, bone cysts and osteophyte formation in a preclinical model of osteoarthritis. | Drug Deliv | 2018 | https://conductscience.org/library/papers/29890922 | PubMed |
| 29385156 | Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: A nationwide, retrospective, matched-cohort study in Taiwan. | PLoS One | 2018 | https://conductscience.org/library/papers/29385156 | PubMed |
| 28988296 | Pivotal factors for successful withdrawal of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients in remission or with low-disease activity. | Clin Rheumatol | 2018 | https://conductscience.org/library/papers/28988296 | PubMed |
| 28507652 | Practice guidelines for pharmacists: The management of osteoarthritis. | Can Pharm J (Ott) | 2017 | https://conductscience.org/library/papers/28507652 | PubMed |
| 28355351 | Naringenin regulates production of matrix metalloproteinases in the knee-joint and primary cultured articular chondrocytes and alleviates pain in rat osteoarthritis model. | Braz J Med Biol Res | 2017 | https://conductscience.org/library/papers/28355351 | PubMed |
| 28067815 | Marine Oil Supplements for Arthritis Pain: A Systematic Review and Meta-Analysis of Randomized Trials. | Nutrients | 2017 | https://conductscience.org/library/papers/28067815 | PubMed |
| 27196460 | Efficacy and Safety of Celecoxib Therapy in Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials. | Medicine (Baltimore) | 2016 | https://conductscience.org/library/papers/27196460 | PubMed |
| 26464847 | A Review on the Management of Hip and Knee Osteoarthritis. | Int J Chronic Dis | 2013 | https://conductscience.org/library/papers/26464847 | PubMed |
| 26212849 | Effectiveness of diclofenac versus paracetamol in knee osteoarthritis: a randomised controlled trial in primary care. | Br J Gen Pract | 2015 | https://conductscience.org/library/papers/26212849 | PubMed |
| 26083352 | Eupatilin Exerts Antinociceptive and Chondroprotective Properties in a Rat Model of Osteoarthritis by Downregulating Oxidative Damage and Catabolic Activity in Chondrocytes. | PLoS One | 2015 | https://conductscience.org/library/papers/26083352 | PubMed |
| 25970845 | Long-term frequent use of non-steroidal anti-inflammatory drugs might protect patients with ankylosing spondylitis from cardiovascular diseases: a nationwide case-control study. | PLoS One | 2015 | https://conductscience.org/library/papers/25970845 | PubMed |
| 25227451 | Management of fibromyalgia in older adults. | Drugs Aging | 2014 | https://conductscience.org/library/papers/25227451 | PubMed |
| 24924603 | Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with knee osteoarthritis: a randomized controlled non-inferiority trial. | Clin Rheumatol | 2016 | https://conductscience.org/library/papers/24924603 | PubMed |
| 24362751 | Clinical management of patients with hip and knee osteoarthritis: patient satisfaction with treatment switch. | Rheumatol Int | 2014 | https://conductscience.org/library/papers/24362751 | PubMed |
| 24267197 | Use of NSAIDs in treating patients with arthritis. | Arthritis Res Ther | 2013 | https://conductscience.org/library/papers/24267197 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10693878
GET https://conductscience.org/api/papers/v1/10693878/cited_by?page=2